Post-Therapy Profile of BMI-for-Age of Indian Survivors of Pediatric Acute Lymphoblastic Leukemia and Non-Hodgkin’s Lymphoma

Chanda D. Gokhale, Shobha A. Udipi, Ramakrishna Y. Ambaye, Suresh K. Pai, Suresh H. Advani

Consultant, Jaslok Hospital, Mumbai, India.
Former Consultant, Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India.
Professor and Head, University Dept of Food Science and Nutrition, S.N.D.T Women’s University, Mumbai, India.
Research Advisor in Pharmacology, Departmenst of Pharmaceutical Sciences and Technology, Institute of Chemical Technology, Mumbai, India.
Smt. P.N. Doshi Women’s College, S.N.D.T Women’s University, Mumbai. Formerly, University Dept of Food Science and Nutrition, S.N.D.T Women’s University, Mumbai, India.

DOI: 10.4236/fns.2012.310185                

Abstract

Background: Obesity in pediatric ALL survivors is a well recognized late effect. Hence the present study examines the BMI-for-age of Indian childhood ALL and NHL survivors. Method: A retrospective study of 118 ALL/NHL survivors and 138 age sex matched was carried out. From the recorded heights and weights were body mass index (BMI) was computed. The survivor data was compared with 138 controls from the data set collected by investigators previously. Results: 82.8% of patients had BMI-for-age in 5th-84th percentile (healthy) at time of diagnosis and at inclusion in the study. Comparison of BMI of survivors with matched controls was not significant. However, The mean BMI-for-age for younger patients (3 to 12 years) was significantly higher than mean BMI-for-age of matched controls. Distribution of data by time elapsed from therapy was significant. Overweight/obesity was observed among the survivors who were off therapy for two years with increase in after four years post-therapy. Conclusion: Our preliminary study indicates late effects of therapy and points to the need of long term assessment of the survivors, even though majority of them were within the normal weight range.

Keywords

Body Mass Index; Children; Indian; Acute Lymphoblastic Leukemia; Non-Hodgkin’s Lymphoma

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	C. A. Sklar, A. C. Mertens, A. Walter, D. Mitchell, M. E. Nesbit, M. O’Leary, R. Hutchison, A. T. Meadows and L. L. Robison, “Changes in Body Mass Index and Prevalence of Overweight in Survivors of Childhood Acute Lymphoblastic Leukemia: Role of Cranial Irradiation,” Medical and Pediatric Oncology, Vol. 35, No. 2, 2000, pp. 91-95. doi:10.1002/1096-911X(200008)35:2<91::AID-MPO1>3.0.CO;2-G
[2]	E. G. Garmey, Q. Liu, C. A. Sklar, L. R. Meacham, A. C. Mertens, M. A. Stovall, Y. Yasui, L. L. Robison and K. C. Oeffinger, “Longitudinal Changes in Obesity and Body Mass Index among Adult Survivors of Childhood Acute Lymphoblastic Leukemia: A Report from the Childhood Cancer Survivor Study,” Journal of Clinical Oncology, Vol. 26, No. 28, 2008, pp. 4639-4645. doi:10.1200/JCO.2008.16.3527
[3]	K. C. Oeffinger, A. C. Mertens, C. A. Sklar, Y. Yasui, T. Fears, M. Stovall, T. A. Vik, P. D. Inskip and L. L. Robison, “Obesity in Adult Survivors of Childhood Acute Lymphoblastic Leukemia: A Report from the Childhood Cancer Survivor Study,” Journal of Clinical Oncology, Vol. 21, No. 7, 2003, pp. 1359-1365. doi:10.1200/JCO.2003.06.131
[4]	C. Papadia, L. A. Naves, S. S. S. Costa, J. A. R. Vaz, L. Domingues and L. A. Casulari, “Incidence of Obesity Does Not Appear to Be Increased after Treatment of Acute Lymphoblastic Leukemia in Brazilian Children: Role of Leptin, Insulin and IGF-I,” Hormone Research, Vol. 68, No. 4, 2007, pp. 164-170. doi:10.1159/000100781
[5]	S. Skoczen, P. J. Tomasik, M. Bik-Multanowski, M. Surmiak, W. Balwierz, J. J. Pietrzyk, K. Sztefko, J. Gozdzik, D. Galicka-Lata?a and W. Strojny, “Plasma Levels of Leptin and Soluble Leptin Receptor and Polymorphisms of Leptin Gene-18G > A and Leptin Receptor Genes K109R and Q223R, in Survivors of Childhood Acute Lymphoblastic Leukemia,” Journal of Experimental & Clinical Cancer Research, Vol. 30, 2011, p. 64. doi:10.1186/1756-9966-30-64
[6]	E. J. Chow, C. Pihoker, K. Hunt, K. Wilkinson and D. L. Friedman, “Obesity and Hypertension among children After Treatment for Acute Lymphoblastic Leukemia,” Cancer, Vol. 110, No. 10, 2007, pp. 2313-2320. doi:10.1002/cncr.23050
[7]	J. Baillargeon, A. M. Langevin, M. Lewis, J. J. Grady, P. J. Thomas, J. Mullins, J. J. Estrada, A. Pitney, N. Sacks and B. H. Pollock, “Therapy-Related Changes in Body Size in Hispanic Children with Acute Lymphoblastic Leukemia,” Cancer, Vol. 103, No. 8, 2005, pp. 1725-1729. doi:10.1002/cncr.20948
[8]	I. Màrky, L. Mellander, B. Lannering and K. AlbertssonWikland, “A Longitudinal Study of Growth and Growth Hormone Secretion in Children during Treatment for Acute Lymphoblastic Leukemia,” Medical and Pediatric Oncology, Vol. 19, No. 4, 1991, pp. 258-264. doi:10.1002/mpo.2950190409
[9]	J. H. Davies, B. A. Evans, E. Jones, W. D. Evans, M. E. Jenney and J. M. Gregory, “Osteopenia, Excess Adiposity and Hyperleptinaemia during 2 Years of Treatment for Childhood Acute Lymphoblastic Leukaemia without Cranial Irradiation,” Clinical Endocrinology, Vol. 60, No. 3, 2004, pp. 358-365.
[10]	L. Iughetti, P. Bruzzi, B. Predieri and P. Paolucci, “Obesity in Patients with Acute Lymphoblastic Leukemia in Childhood,” Italian Journal of Pediatrics, Vol. 38, No. 4, 2012. doi:10.1186/1824-7288-38-4
[11]	S. Advani, S. Pai, D. Venzon, M. Adde, P. K. Kurkure, C. N. Nair, B. Sirohi, S. D. Banavali, R. Hawaldar, B. B. Kolhatkar, T. Vats and I. Magarth, “Acute Lymphoblastic Leukemia in India: An Analysis of Prognostic Factors Using a Single Treatment Regimen,” Annals of Oncology, Vol. 10, No. 2, 1999, pp. 167-176. doi:10.1023/A:1008366814109
[12]	S. Bhave, A. Bavdekar and M. Otiv M, “IAP National Task Force for Childhood Prevention of Adult Diseases,” Indian Pediatrics, Vol. 41, No. 6, 2004, pp. 559-575.
[13]	J. J. Reilly, “Obesity during and after Treatment for Childhood Cancer,” In: W. H. B. Wallace and C. J. H. Kelnar, Eds., Endocrinopathy after Childhood Cancer Treatment, Endocr Dev. Basel, Karger, 2009, pp 40-58. doi:10.1159/000207609
[14]	R. Kumar, R. K. Marwaha, A. K. Bhalla and M. Gulati, “Protein Energey Malnutrition and Skeletal Muscle Wasting in Childhood Acute Lymphoblastic Leukemia,” Italian Journal of Pediatrics, Vol. 37, No. 7, 2000, pp. 720726.
[15]	P. Zee and C. H. Chen, “Prevalence of Obesity in Children after Therapy for Acute Lymphoblastic Leukemia,” American Journal of Pediatric Hematology/Oncology, Vol. 8, No. 4, 1986, pp. 294-299. doi:10.1097/00043426-198624000-00005
[16]	S. Pakakasama, G. Veerakul, D. Sosothikul, S. O. Chainansamit, V. Laosombat, P. Thanarattanakorn, R. Lumkul, S. Wiangnon, S. Wangruangsathit, N. Narkbunnam and S. Kanjanapongkul, “Late Effects in Survivors of Childhood Acute Lymphoblastic Leukemia: A Study from Thai Pediatric Oncology Group,” International Journal of Hematology, Vol. 91, No. 5, 2010, pp. 850-854. doi:10.1007/s12185-010-0594-9
[17]	E. I. Mayer, M. Reuter, R. E. Dopfer and M. B. Ranke, “Energy Expenditure, Energy Intake and Prevalence of Obesity after Therapy for Acute Lymphoblastic Leukemia during Childhood,” Hormone Research, Vol. 53, No. 4, 2000, pp. 93-99. doi:10.1159/000023566
[18]	T. Midha, B. Nath, R. Kumari, Y. K. Rao and U. Pandey, “Childhood Obesity in India: A Meta-Analysis,” Indian Journal of Pediatrics, Vol. 79, No. 7, 2012, pp. 945-948. doi:10.1007/s12098-011-0587-6
[19]	G. Srihari, A. Eilander, S. Muthayya, A. V. Kurpad and S. Seshadri, “Nutritional Status of Affluent Indian School Children: What and How Much Do We Know?” Italian Journal of Pediatrics, Vol. 44, No. 3, 2007, pp. 204-213.
[20]	J. J. Reilly, A. Kelly, P. Ness, R. Ahmad, W. Dorosty, H. B. Wallace, B. E. S. Gibson, P. P. M. Emmett and the ALSPAC Study Team, “Premature Adiposity Rebound in Children Treated for Acute Lymphoblastic Leukemia,” Journal of Clinical Endocrinology & Metabolism, Vol. 86, No. 6, 2001, pp. 2775-2778. doi:10.1210/jc.86.6.2775
[21]	J. T. Warner, “Body Composition, Exercise and Energy Expenditure in Survivors of ALL,” Pediatric Blood and Cancer, Vol. 50, No. 2, 2008, pp. 456-461. doi:10.1002/pbc.21411
[22]	S. Lowas, S. Malempati and D. Marks, “Body Mass Index Predicts Insulin Resistance in Survivors of Pediatric Acute Lymphoblastic Leukemia,” Pediatric Blood Cancer, Vol. 53, No. 1, 2009, pp. 58-63. doi:10.1002/pbc.21993
[23]	R. A. Niinim?ki, A. H. Harila-Saari, A. E. Jartti, R. M. Seuri, P. V. Riikonen, E. L. P??kk?, M. I. M?tt?nen and M. Lanning, “High Body Mass Index Increases the Risk for Osteonecrosis in Children with Acute Lymphoblastic Leukemia,” Journal of Clinical Oncology, Vol. 25, No. 12, 2007, pp. 1498-1504. doi:10.1200/JCO.2006.06.2539